Skip to main content
HR 5402 116th Congress House Taxation Drug safety, medical device, and laboratory regulation Drug therapy Government studies and investigations Income tax credits Medical research

Protecting America’s Life Saving Medicines Act of 2019

Introduced: December 11, 2019 Introduced by: Gottheimer, Josh Democratic · New Jersey See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 12, 2019
Referred to the Subcommittee on Health.
Dec 11, 2019
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Dec 11, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Protecting America's Life Saving Medicines Act of 2019

This bill directs the Food and Drug Administration (FDA) to conduct a study on drugs that are currently being tested and are unlikely to be approved, but would, if approved, address an unmet medical need for the treatment of a serious or life threatening disease or condition or a rare disease or condition (high-risk, high-reward drugs). The FDA must submit to the Department of the Treasury a list of such high-risk, high-reward drugs not later than 180 days after the completion of the study.

The bill also allows a new tax credit for 25% of the clinical testing expenses for high-risk, high-reward drugs.

What's happening now December 12, 2019

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 2
All 2 Republican 1
R
Fitzpatrick, Brian K.
Pennsylvania · Dec 18, 2019
UPTON, FRED
· Dec 11, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5402: Protecting America’s Life Saving Medicines Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5402/
MLA
"H.R. 5402: Protecting America’s Life Saving Medicines Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5402/.
Bluebook (legal)
H.R. 5402, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5402/.
Markdown link
[H.R. 5402: Protecting America’s Life Saving Medicines Act of 2019](https://openamerica.io/bill/116-HR-5402/)
Report a problem